Wall St slips after mixed earnings as jobs report looms

Valeant (VRX) Price Target Cut to $195 at Guggenheim; Thesis Intact

Guggenheim analyst Louise Chen lowered her price target on Valeant Pharmaceuticals (NYSE: VRX) to $195.00 (from $300.00) but maintained a Buy rating saying the investment thesis remains intact.

Chen commented, "We are lowering our PT for VRX to $195 from $300. The decrease in our PT is... More

Cowen Reiterates Outperform on Celgene (CELG) Following a Soft 3Q

Cowen reiterated an Outperform rating and $150.00 price target on Celgene (NASDAQ: CELG), following the company's 3Q earnings report. Celgene reported non-GAAP EPS of $1.23, slightly beating consensus of $1.21. Revenues of $2.33B compared to consensus of $2.39B. TThe 18% growth in product sales was driven... More

Cowen Trims PT on Qualcomm (QCOM) to $69; QCT Faring Better, QTL Worse

Cowen and Company is lowering its price target on Outperform-rated Qualcomm (Nasdaq: QCOM) from $72 to $69 following Q3 results issued Wednesday night.

On the results, Analyst Tim Arcuri commented, While QCT we believe has found a bottom, QTL collections continue to lag... More

Facebook (FB) PT Raised to $135 at Canaccord Genuity

Canaccord Genuity reiterated a Buy rating and boosted its price target on Facebook (NASDAQ: FB) to $135.00 (from $115.00).

The analyst commented, "Facebook's Q3 results were strong yet again, with revenue beating consensus by 3% and EPS beating by 9%. Facebook delivered another well-rounded growth quarter, with MAU growth... More

Facebook (FB) Lifted to $125 at JPMorgan; Accelerating Ad Revenue the Highlight

JPMorgan analyst Doug Anmuth reiterated an Overweight rating and lifted his price target on Facebook (NASDAQ: FB) to $125.00 (from $118.00) following strong Q3 results highlighted by accelerating ad revenue growth.

Anmuth commented, "FB delivered another strong qtr w/accelerating growth in both FXN ad revenue to 57% Y/Y & total MAUs to 14% at 1.545B. Non-GAAP op margins of... More

Facebook (FB) PT Raised to $120 at Nomura on Strong Q3

Nomura Securities analyst Anthony DiClemente reiterated a Buy rating and boosted his price target on Facebook (NASDAQ: FB) to $120.00 (from $115.00) following strong Q3 results.

DiClemente commented, "3Q results for Facebook exemplify steady growth, as revenue, operating income, and EPS all came in... More

Whole Foods Market (WFM) Guides Square Footage Growth Down to 7%; Piper Jaffray Remains Neutral

Piper Jaffray maintained a Neutral rating on Whole Foods Market (NASDAQ: WFM), and cut the price target to $30.00 (from $34.00), following the company's 4Q earnings report. Comparable sales continue to decelerate at Whole Foods as the retailer struggles to drive traffic to its stores. Q4 comps of (0.2%) compare to +0.7% consensus; traffic growth was (0.8%) while average basket grew... More

Facebook (FB) Strong Q3 Shows It's 'Still the One', Goldman Sachs Says; PT Raised to $125

Goldman Sachs analyst Heather Bellini reiterated a Buy rating and lifted her price target on Facebook (NASDAQ: FB) to $125.00 (from $110.00) following strong Q3 results highlighted with accelerating ad revenue growth. Bellini said Facebok is "still the one."

Bellini notes total revenue of $4.50bn (+41% yoy,... More

Facebook (FB) Estimates Raised at Needham & Company Amid Strong Q3, Outlook

Needham & Company analyst Laura Martin reiterated a Buy rating and $115 price target on Facebook (NASDAQ: FB) following strong Q3 results and outlook.

Martin commented, "FB reported strong 3Q15 results with revenue of $4.5B (up 41% y/y and 2% above our estimate), and EPS of... More

Facebook (FB) PT Raised to $116 at Baird Amid Strong Q3

Baird analyst Colin Sebastian reiterated an Outperform rating and boosted his price target on Facebook (NASDAQ: FB) to $116.00 (from $110.00) following strong Q3.

Sebastian commented, "Facebook is benefiting from significant advantages afforded to large Internet platform companies in the form of innovation, scale, resources, and... More

Facebook (FB) Forex Neutral Ad Growth at 57%, Raymond James Notes; PT Lifted to $120

Raymond James analyst Aaron Kessler reiterated an Outperform rating and boosted his price target on Facebook (NASDAQ: FB) to $120.00 (from $115.00).

Kessler commented, "Facebook reported a strong 3Q marked by 57% y/y forex neutral ad revenue growth, 72% y/y mobile revenue growth, and solid... More